Johnson & Johnson’s first-ever clinical study in psoriasis with patients of color found its treatment Tremfya works similarly across diverse populations,...
A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from...
Merck’s blockbuster cancer drug Keytruda made $18.4 billion in the first nine months of the year — nearly the same amount as the reported revenue of...
After the TSX hit a two-week low a few days ago, the Bank of Canada delivered a lower-than-expected rise in interest rates. The post Buzz on...
If all goes well at the FDA, AstraZeneca hopes to roll out the US’ first self-administered flu vaccine ahead of the next cold and flu season,...
Heartland BioWorks, which has assembled partners that bring together biotech and manufacturing research and resources, will focus on the development of...
Novo Nordisk’s Rybelsus pill was long expected to be a hit out of the gate. The Danish drugmaker cashed in a priority review voucher in early...
Verve Therapeutics is planning to begin an in-human base editing trial in the US in patients with heterozygous familial hypercholesterolemia (HeFH) after...
The cold medicine aisle is about to look a lot different.
MADRID — When Daiichi Sankyo scientists pushed forward with antibody-drug conjugate research nearly a decade ago, the program had a lot of naysayers,...
MADRID — Seagen and Astellas Pharma drew a standing ovation from thousands of ESMO delegates on Sunday as the companies unveiled further data from a...
MADRID — Seagen and Astellas Pharma drew a standing ovation from thousands of ESMO delegates on Sunday as the companies unveiled further data from a...
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal...
Behind A Secret Chinese Biolab In California, A Global Web Of Connections Authored by Steve Ispas and Lear Zhou via The Epoch Times (emphasis...
The FDA's Ties To The Gates Foundation Authored by Maryanne Demasi via The Brownstone Institute, In 2017, the US Food and Drug Administration...
Eli Lilly is bolstering the case for its experimental eczema treatment lebrikizumab with a first look at how patients fared after two years of maintenance...
The US Food and Drug Administration has reported that the decongestant phenylephrine, taken in oral form, does not work.
Cyrus Harmon → Ex-Olema Oncology chief Cyrus Harmon has resurfaced as CEO of Vilya, a Seattle-based macrocycle biotech from David Baker’s lab that...
Johnson & Johnson is ramping up manufacturing capacity for the CAR-T therapy it developed with Legend Biotech, driven by high demand for the Carvykti,...
Are the best penny stocks to buy, cheap stocks under $1? The post Best Penny Stocks Under $1? 4 To Watch This Week appeared first on...
The number one thing most people fear as they age is developing dementia. As the world’s population becomes increasingly older, this is a growing public...
Digital health tools and technologies were thrust into the spotlight during the pandemic and were able to help many people get much needed medical advice...
Digitization of clinical trials isn’t particularly new. Today, electronic data capture is only one of myriad technologies deployed in clinical trials...
Bristol Myers Squibb’s subcutaneous formulation of its cancer blockbuster Opdivo proved noninferior to intravenous Opdivo in a Phase III trial, the company...
Johnson & Johnson is ramping up manufacturing capacity for the CAR-T therapy it developed with Legend Biotech, driven by high demand for the Carvykti,...
The system is entirely non-invasive and could have near-term applications for some. The new system combines a non-invasive brain scanning...
Michelle Teng, CEO and co-founder of Etcembly and co-founder of SynaptixBio, spoke with Inside Precision Medicine's senior editor Helen Albert about her...
The European Medicines Agency has been notified by relevant national authorities that pre-filled pens falsely labeled as the type 1 diabetes medicine...
Precision medicines are gaining increasing traction in healthcare. Here are five companies driving the field with recent approvals in RNA therapeutics,...
By Benjamin Boettner Credit: Wyss Institute at Harvard University By Benjamin Boettner (BOSTON) — The Biomedical Advanced Research and Development Authority (BARDA),...